Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,258.26
-44.89 (-3.44%)
At close: Oct 22, 2026
EGX:AXPH Income Statement
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 3,177 | 2,751 | 1,768 | 1,484 | 1,100 |
Other Revenue | 5.95 | 11.24 | - | - | 0 |
| 3,183 | 2,762 | 1,768 | 1,484 | 1,100 | |
Revenue Growth | 15.24% | 56.20% | 19.12% | 34.94% | -0.38% |
Cost of Revenue | 2,368 | 2,092 | 1,373 | 1,223 | 876.78 |
Gross Profit | 814.08 | 670.19 | 395.18 | 260.89 | 223.24 |
Selling, General & Admin | 101.71 | 103.09 | 89.77 | 83.52 | 75.65 |
Other Operating Expenses | 39.87 | 62.4 | 37.92 | 22.44 | 13.05 |
Operating Expenses | 141.58 | 165.49 | 127.69 | 105.96 | 88.7 |
Operating Income | 672.5 | 504.7 | 267.49 | 154.92 | 134.54 |
Interest & Investment Income | 22.3 | 19.56 | 13.52 | 5.52 | 5.55 |
Currency Exchange Gain (Loss) | -2.18 | -3.01 | 8.03 | 11.57 | 4.4 |
Other Non Operating Income (Expenses) | - | - | 0 | 0 | - |
EBT Excluding Unusual Items | 692.62 | 521.25 | 289.04 | 172.02 | 144.49 |
Gain (Loss) on Sale of Assets | 0.04 | - | 0.56 | 1.03 | - |
Other Unusual Items | -11.47 | -12.34 | -7.57 | -8.1 | -0.99 |
Pretax Income | 681.19 | 508.9 | 282.03 | 164.95 | 143.5 |
Income Tax Expense | 156.39 | 117.74 | 65.35 | 38.52 | 26.08 |
Net Income | 524.8 | 391.17 | 216.68 | 126.43 | 117.42 |
Net Income to Common | 524.8 | 391.17 | 216.68 | 126.43 | 117.42 |
Net Income Growth | 34.16% | 80.53% | 71.39% | 7.67% | 0.36% |
Shares Outstanding (Basic) | 6 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 6 | 5 | 5 | 5 | 5 |
Shares Change | 5.18% | 7.39% | - | - | - |
EPS (Basic) | 92.92 | 72.85 | 43.34 | 25.29 | 23.48 |
EPS (Diluted) | 92.92 | 72.85 | 43.34 | 25.29 | 23.48 |
EPS Growth | 27.55% | 68.10% | 71.39% | 7.67% | 0.36% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 432.45 | 306.27 | 127.41 | 7.09 | 160.9 |
Free Cash Flow Per Share | 76.57 | 57.04 | 25.48 | 1.42 | 32.18 |
Dividend Per Share | 63.000 | 62.950 | 30.000 | 13.000 | - |
Dividend Growth | 0.08% | 109.83% | 130.77% | 30.00% | - |
Gross Margin | 25.58% | 24.27% | 22.35% | 17.58% | 20.29% |
Operating Margin | 21.13% | 18.27% | 15.13% | 10.44% | 12.23% |
Profit Margin | 16.49% | 14.16% | 12.26% | 8.52% | 10.67% |
Free Cash Flow Margin | 13.59% | 11.09% | 7.21% | 0.48% | 14.63% |
EBITDA | 720.93 | 547.92 | 305.05 | 182.92 | 157.73 |
EBITDA Margin | 22.65% | 19.84% | 17.25% | 12.32% | 14.34% |
D&A For EBITDA | 48.42 | 43.22 | 37.56 | 28 | 23.18 |
EBIT | 672.5 | 504.7 | 267.49 | 154.92 | 134.54 |
EBIT Margin | 21.13% | 18.27% | 15.13% | 10.44% | 12.23% |
Effective Tax Rate | 22.96% | 23.14% | 23.17% | 23.35% | 18.17% |
Revenue as Reported | 3,183 | 2,762 | 1,777 | 1,486 | 1,101 |